Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Short-term Investments (2024 - 2025)

Historic Short-term Investments for Arcturus Therapeutics Holdings (ARCT) over the last 2 years, with Q3 2025 value amounting to $55.0 million.

  • Arcturus Therapeutics Holdings' Short-term Investments changed 0.0% to $55.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $55.0 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Arcturus Therapeutics Holdings' Short-term Investments is $55.0 million, which was down 0.0% from $55.0 million recorded in Q2 2025.
  • Arcturus Therapeutics Holdings' Short-term Investments' 5-year high stood at $55.0 million during Q1 2024, with a 5-year trough of $38.5 million in Q1 2025.